ZA936504B - Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. - Google Patents
Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure.Info
- Publication number
- ZA936504B ZA936504B ZA936504A ZA936504A ZA936504B ZA 936504 B ZA936504 B ZA 936504B ZA 936504 A ZA936504 A ZA 936504A ZA 936504 A ZA936504 A ZA 936504A ZA 936504 B ZA936504 B ZA 936504B
- Authority
- ZA
- South Africa
- Prior art keywords
- eye
- intraocular pressure
- topical application
- pharmaceutical composition
- increased intraocular
- Prior art date
Links
- 230000004410 intraocular pressure Effects 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 230000004406 elevated intraocular pressure Effects 0.000 abstract 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
- 229960000367 inositol Drugs 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 229960001855 mannitol Drugs 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940054534 ophthalmic solution Drugs 0.000 abstract 1
- 239000002997 ophthalmic solution Substances 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 229960002920 sorbitol Drugs 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4229494A DE4229494A1 (de) | 1992-09-04 | 1992-09-04 | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA936504B true ZA936504B (en) | 1995-03-03 |
Family
ID=6467184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA936504A ZA936504B (en) | 1992-09-04 | 1993-09-03 | Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5527831A (cs) |
| EP (1) | EP0585896B1 (cs) |
| JP (1) | JPH06172158A (cs) |
| KR (1) | KR940006575A (cs) |
| CN (1) | CN1086132A (cs) |
| AT (1) | ATE145823T1 (cs) |
| AU (1) | AU673533B2 (cs) |
| CA (1) | CA2105530A1 (cs) |
| CZ (1) | CZ284095B6 (cs) |
| DE (2) | DE4229494A1 (cs) |
| DK (1) | DK0585896T3 (cs) |
| ES (1) | ES2096161T3 (cs) |
| GR (1) | GR3022225T3 (cs) |
| HU (1) | HU213272B (cs) |
| NO (1) | NO933140L (cs) |
| NZ (1) | NZ248567A (cs) |
| PL (1) | PL300286A1 (cs) |
| SK (1) | SK79893A3 (cs) |
| ZA (1) | ZA936504B (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716819B2 (en) * | 2000-05-19 | 2004-04-06 | University Of Iowa Research Foundation | Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| MY128762A (en) | 2001-01-12 | 2007-02-28 | Novartis Ag | Lens care product containing dexpanthenol |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| JP2005035969A (ja) * | 2003-06-25 | 2005-02-10 | Lion Corp | 眼科用組成物及び該組成物の安定化方法 |
| US8569367B2 (en) † | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
| IL168603A (en) * | 2005-05-16 | 2011-05-31 | Resdevco Res And Dev Co | Pharmaceutical or cosmetic composition for the prevention and treatment of irritation of mucous cells or skin cells |
| US9911989B2 (en) * | 2005-07-25 | 2018-03-06 | Bloom Energy Corporation | Fuel cell system with partial recycling of anode exhaust |
| SI2148667T1 (sl) * | 2007-04-12 | 2013-12-31 | Waratah Pharmaceuticals, Inc. | Uporaba derivatov cikloheksanheksola pri zdravljenju okularnih bolezni |
| US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
| CN104114152A (zh) | 2011-12-07 | 2014-10-22 | 阿勒根公司 | 用盐敏性乳液体系对人泪液膜进行有效脂质递送 |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| KR102487299B1 (ko) | 2014-11-25 | 2023-01-10 | 알러간, 인코포레이티드 | 안정화된 오메가-3 안과용 조성물 |
| ITUB20153104A1 (it) * | 2015-08-13 | 2017-02-13 | Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm | Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4201706A (en) * | 1978-09-22 | 1980-05-06 | Burton, Parsons & Company, Inc. | Treatment of corneal edema |
| CY1361A (en) * | 1980-03-21 | 1987-08-07 | Wellcome Found | Stabilised ophthalmic formulation |
| US4396625A (en) * | 1980-05-13 | 1983-08-02 | Sumitomo Chemical Company, Limited | Treatment of glaucoma or ocular hypertension and ophthalmic composition |
| IL80298A (en) * | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| DE3700379A1 (de) * | 1987-01-08 | 1988-07-21 | Mann Gerhard Chem Pharm Fab | Konservierte augentropfen mit einem gehalt an cromoglicinsaeure |
| FR2661832A1 (fr) * | 1990-05-11 | 1991-11-15 | Corbiere Jerome | Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues. |
-
1992
- 1992-09-04 DE DE4229494A patent/DE4229494A1/de not_active Withdrawn
-
1993
- 1993-07-28 SK SK798-93A patent/SK79893A3/sk unknown
- 1993-08-19 US US08/109,417 patent/US5527831A/en not_active Expired - Lifetime
- 1993-09-01 EP EP93113966A patent/EP0585896B1/de not_active Expired - Lifetime
- 1993-09-01 ES ES93113966T patent/ES2096161T3/es not_active Expired - Lifetime
- 1993-09-01 AT AT93113966T patent/ATE145823T1/de not_active IP Right Cessation
- 1993-09-01 DE DE59304658T patent/DE59304658D1/de not_active Expired - Fee Related
- 1993-09-01 DK DK93113966.1T patent/DK0585896T3/da active
- 1993-09-02 CZ CZ931811A patent/CZ284095B6/cs unknown
- 1993-09-02 KR KR1019930017455A patent/KR940006575A/ko not_active Withdrawn
- 1993-09-02 NZ NZ248567A patent/NZ248567A/en unknown
- 1993-09-03 JP JP5218945A patent/JPH06172158A/ja active Pending
- 1993-09-03 CA CA002105530A patent/CA2105530A1/en not_active Abandoned
- 1993-09-03 PL PL93300286A patent/PL300286A1/xx unknown
- 1993-09-03 NO NO933140A patent/NO933140L/no unknown
- 1993-09-03 AU AU46105/93A patent/AU673533B2/en not_active Ceased
- 1993-09-03 HU HU9302502A patent/HU213272B/hu not_active IP Right Cessation
- 1993-09-03 CN CN93117348A patent/CN1086132A/zh active Pending
- 1993-09-03 ZA ZA936504A patent/ZA936504B/xx unknown
-
1997
- 1997-01-08 GR GR970400003T patent/GR3022225T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9302502D0 (en) | 1993-11-29 |
| NZ248567A (en) | 1995-11-27 |
| DE4229494A1 (de) | 1994-03-10 |
| EP0585896B1 (de) | 1996-12-04 |
| NO933140D0 (no) | 1993-09-03 |
| CN1086132A (zh) | 1994-05-04 |
| HUT64836A (en) | 1994-03-28 |
| KR940006575A (ko) | 1994-04-25 |
| HU213272B (en) | 1997-04-28 |
| US5527831A (en) | 1996-06-18 |
| SK79893A3 (en) | 1994-08-10 |
| JPH06172158A (ja) | 1994-06-21 |
| AU4610593A (en) | 1994-03-10 |
| ATE145823T1 (de) | 1996-12-15 |
| CZ181193A3 (en) | 1994-07-13 |
| AU673533B2 (en) | 1996-11-14 |
| GR3022225T3 (en) | 1997-04-30 |
| PL300286A1 (en) | 1994-03-07 |
| CA2105530A1 (en) | 1994-03-05 |
| EP0585896A1 (de) | 1994-03-09 |
| NO933140L (no) | 1994-03-07 |
| ES2096161T3 (es) | 1997-03-01 |
| CZ284095B6 (cs) | 1998-08-12 |
| DE59304658D1 (de) | 1997-01-16 |
| DK0585896T3 (da) | 1997-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA936504B (en) | Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure. | |
| ES2042625T3 (es) | Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular. | |
| EP0834320A4 (en) | ACTIVE COMPOSITION COMPOSED BY ALBUMIN AS AN ACTIVE INGREDIENT | |
| DK54390D0 (da) | Okularcyklosporinpraeparat | |
| EP0045617A3 (en) | Pharmaceutical composition | |
| CA2050284A1 (en) | PCP Receptor Ligands and the Use Thereof | |
| AR011192A1 (es) | Composiciones oftalmicas que comprenden una prostaglandina y el uso de los mismos en la preparacion de un medicamento para tratar glaucoma | |
| ES2127375T3 (es) | Procedimiento de administracion de un farmaco oftalmico. | |
| ES2093400T3 (es) | Composiciones dentifricas. | |
| DK0572190T3 (da) | Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens | |
| ES2141736T3 (es) | Gel, especialmente para uso terapeutico ocular. | |
| EP0363469A4 (en) | Lacrimal secretion stimulant (lss) | |
| CA2294207A1 (en) | Anti-chlamydia agent | |
| CA2025728A1 (en) | Antimicrobial compositions | |
| KR880001290A (ko) | β-차단제 및 필로카르핀-함유 제제 | |
| BR9813855A (pt) | Uso de flunarizina, ou de um seu sal farmaceuticamente aceitável, e, composição oftálmica tópica para o tratamento e/ou a profilaxia do glaucoma | |
| EP0345028A3 (en) | Treatment of glaucoma using phosphodiesterase inhibitor | |
| PT92538A (pt) | Processo para a formulacao para o conforto do olho para terapeutica do glaucoma, compreendendo inter alia um polimero mucomimetrico anionico | |
| LEE et al. | A Case of Endophthalmitis after Laser in situ Keratomi leusisLASIK | |
| HA | Megalo-bleb phenomenon | |
| KOOK et al. | Efficacy and Safety of Subconjunctivally Injected 5-fluorouracil after Mitomycin C Trabeculectomy in High Risk Patients | |
| IT1272740B (it) | Composizioni farmaceutiche contenenti una sostanza attiva fosfatidilinositolo atte alla terapia delle neurpatie periferiche da diabete mellito | |
| IT1241928B (it) | Composizione oftalmica per l'uso nel mantenimento della midriasi oculare |